Twist Bioscience Corp — Director's Dealing 2021

Mar 5, 2021

SEC Form 4/A — Form 4/A

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2019-10-24

Reporting Person: BARTHELEMY NICOLAS (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-24	Director Stock Option (right to buy)	$23.33	A	25361	Acquired	2029-10-23	Common Stock (25361)	Direct

Footnotes

F1: The Form 4 originally filed on October 28, 2019 incorrectly reported 14,573 options.

F2: 1/3rd of the shares subject to the option vest and become exercisable on October 24, 2020, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.